29

研究癌症领域必看文献

最近需要了解一些癌症相关知识,看到了这个文献列表,觉得非常棒,所以推荐给大家。

抽时间慢慢看,一个月应该可以把这些文献看完的。

癌症种类大全 http://www.cancer.gov/types
癌症药物大全 http://www.cancer.gov/about-cancer/treatment/drugs
癌症所有的信息几乎都能在这个网站上面找到 http://www.cancer.gov/
包括癌症的科普、treatment、diagnosis,prognosis,classification,drugs、prediction等等

different_kinds_of_cancer_in_CCLE

Cancer Precision Medicine: Improving Evidence in Practice - August 24, 2015

NCI-MATCH Trial Opens,External Web Site Icon AACR blog post, August 2015

NCI-MATCH launch highlights new trial design in precision-medicine eraExternal Web Site Icon
McNeal C , JNCI, August 2015

The Cancer Genomics Resource List, 2014External Web Site Icon
Zutter MM et al. CAP Lab Improvement Program,Archives of Pathology, August 2015

Personalized medicine and economic evaluation in oncology: all theory and no practice?External Web Site Icon
Garattini L et al. Expert Rev Pharmacoecon Outcomes Res 2015 Aug 9. 1-6

Precision medicine trials bring targeted treatments to more patients,External Web Site Icon C. Helwick, ASCO Post, Jul 25

Next-generation sequencing to guide cancer therapy External Web Site Icon
Gagan J et al, Genome Medicine, July 29, 2015

Feasibility of large-scale genomic testing to facilitate enrollment onto genomically matched clinical trials.External Web Site Icon
Meric-Bernstam F et al. J. Clin. Oncol. 2015 May 26.

Brave-ish new world-what's needed to make precision oncology a practical reality.External Web Site Icon
MacConaill LE et al. JAMA Oncol 2015 Jul 16.

Genomic profiling: Building a continuum from knowledge to careExternal Web Site Icon
Helen C et al. JAMA Oncology, July 2015

Are we there yet?External Web Site Icon
When it comes to curing cancer, targeted therapies and genomic sequencing are helping, but we still have far to go. Genome Magazine, June 29, 2015

Artificial intelligence, big data, and cancerExternal Web Site Icon
Kantarjian H et al, JAMA Oncology, June 2015

Multigene panel testing in oncology practice - how should we respond?External Web Site Icon
Kurian AW et al. JAMA Oncology, June 2015

Use of whole genome sequencing for diagnosis and discovery in the cancer genetics clinic.External Web Site Icon
Foley SB et al. EBioMedicine 2015 Jan 2(1) 74-81

The future of molecular medicine: biomarkers, BATTLEs, and big data External Web Site Icon
ES Kim, ASCO University, June 2015

NCI-MATCH trial will link targeted cancer drugs to gene abnormalitiesExternal Web Site Icon

Targeted agent and profiling utilization registry study,External Web Site Icon from the American Society for Clinical Oncology

ASCO study aims to learn from patient access to targeted cancer drugs used off-label,External Web Site Icon American Society for Clinical Oncology

Improving evidence developed from population-level experience with targeted agents Adobe PDF file [PDF 462.93 KB]External Web Site Icon
McLellan M et al Issue Brief. Conference on Clinical Cancer Research November 2014

Implementing personalized cancer care.External Web Site Icon
Schilsky RL et al. Nat Rev Clin Oncol 2014 Jul (7) 432-8

Accelerating the delivery of patient-centered, high-quality cancer care.External Web Site Icon
Abrahams E et al. Clin. Cancer Res. 2015 May 15. (10) 2263-7

Next-generation clinical trials: Novel strategies to address the challenge of tumor molecular heterogeneity.External Web Site Icon
Catenacci DV et al. Mol Oncol 2015 May (5) 967-996

Cancer Precision Medicine: Improving Evidence in Practice - May 29, 2015

Diagnosis and treatment of cancer using genomicsExternal Web Site Icon
Vockley JG et al. BMJ, May 28, 2015

Targeted agent and profiling utilization registry study,External Web Site Icon from the American Society for Clinical Oncology

ASCO study aims to learn from patient access to targeted cancer drugs used off-label,External Web Site Icon American Society for Clinical Oncology

Improving evidence developed from population-level experience with targeted agents Adobe PDF file [PDF 462.93 KB]External Web Site Icon
McLellan M et al Issue Brief. Conference on Clinical Cancer Research November 2014

Implementing personalized cancer care.External Web Site Icon
Schilsky RL et al. Nat Rev Clin Oncol 2014 Jul (7) 432-8

Accelerating the delivery of patient-centered, high-quality cancer care.External Web Site Icon
Abrahams E et al. Clin. Cancer Res. 2015 May 15. (10) 2263-7

Next-generation clinical trials: Novel strategies to address the challenge of tumor molecular heterogeneity.External Web Site Icon
Catenacci DV et al. Mol Oncol 2015 May (5) 967-996

Precision Medicine: Cancer and Genomics - May 12, 2015

Promise, peril seen in personalized cancer therapy,External Web Site Iconby Marie McCullough, Philadelphia Inquirer, May 10

A decision support framework for genomically informed investigational cancer therapy.External Web Site Icon
Meric-Bernstam F et al. J. Natl. Cancer Inst. 2015 Jul (7)

Divide and conquer: The molecular diagnosis of cancer,External Web Site Icon by Louis M. Staudt, National Cancer Insitute, Apr 13

Health: Make precision medicine work for cancer careExternal Web Site Icon
To get targeted treatments to more cancer patients pair genomic data with clinical data, and make the information widely accessible, Mark A. Rubin. Nature News, Apr 15

Using somatic mutations to guide treatment decisionsExternal Web Site Icon
Horlings H et al. JAMA Oncology, March 12, 2015

The landscape of precision cancer medicine clinical trials in the United StatesExternal Web Site Icon
Roper N et al. Cancer Treatment Reviews 2015

What is “precision medicine?External Web Site Icon Information from the National Cancer Institute

Impact of cancer genomics on precision medicine for the treatment of cancer,External Web Site Icon from the Cancer Genome Atlas, NCI

US precision-medicine proposal sparks questions,External Web Site Icon by Sara Reardon, Nature News, Jan 22

Obama's 'precision medicine' means gene mapping,External Web Site IconNBC News, Jan 21

What is President Obama's 'precision medicine' plan, and how might it help you?External Web Site Icon By Lenny Bernstein, Jan 21

Recent reviews

Companion diagnostics: the key to personalized medicine.External Web Site Icon
Jørgensen JT. Expert Rev Mol Diagn. 2015 Feb;15(2):153-6

Promoting precision cancer medicine through a community-driven knowledgebase.External Web Site Icon
Geifman N, et al. J Pers Med. 2014 Dec 15;4(4):475-88.

Toward a prostate cancer precision medicine.External Web Site Icon
Rubin MA. Urol Oncol. 2014 Nov 20.

Prioritizing targets for precision cancer medicine.External Web Site Icon
Andre F, et al. Ann Oncol. 2014 Dec;25(12):2295-303

Toward precision medicine with next-generation EGFR inhibitors in non-small-cell lung cancer.External Web Site Icon
Yap TA, Popat S. Pharmgenomics Pers Med. 2014 Sep 19;7:285-95.

Genomically driven precision medicine to improve outcomes in anaplastic thyroid cancer.External Web Site Icon
Pinto N, et al.  J Oncol. 2014;936285

Translating genomics for precision cancer medicine.External Web Site Icon
Roychowdhury S, Chinnaiyan AM. Annu Rev Genomics Hum Genet. 2014;15:395-415

The Cancer Genome Atlas: Accomplishments and Future - April 3, 2015

The Cancer Genome Atlas (TCGA): an immeasurable source of knowledgeExternal Web Site Icon
Tomczak K, et al. Contemp Oncol (Pozn). 2015; 19(1A): A68-A77.

The Cancer Genome Atlas' 4th Annual Scientific SymposiumExternal Web Site Icon
May 11-12 ~ Bethesda, MD

The Cancer Genome Atlas (TCGA) Data Portal External Web Site Icon
Portal provides a platform for researchers to search, download, and analyze data sets generated by TCGA

Cancer Genomics Hub: A resource of the National Cancer Institute,External Web Site Icon from the USC Genome Browser

Molecular classification of gastric adenocarcinoma: translating new insights from The Cancer Genome Atlas Research Network.External Web Site Icon
Sunakawa Y et al. Curr Treat Options Oncol 2015 Apr (4) 331

TCGA data and patient-derived orthotopic xenografts highlight pancreatic cancer-associated angiogenesis.External Web Site Icon
Gore J et al. Oncotarget 2015 Feb 25.

Radiogenomics of clear cell renal cell carcinoma: preliminary findings of The Cancer Genome Atlas-Renal Cell Carcinoma (TCGA-RCC) Imaging Research Group.External Web Site Icon
Shinagare AB et al. Abdom Imaging 2015 Mar 10.

Proteomics of colorectal cancer in a genomic context: First large-scale mass spectrometry-based analysis from the Cancer Genome Atlas.External Web Site Icon
Jimenez CR et al. Clin. Chem. 2015 Feb 26.

End of cancer-genome project prompts rethinkExternal Web Site Icon
Geneticists debate whether focus should shift from sequencing genomes to analysing function. Heidi Ledford, Nature News and Comments, January 2015

Cancer Genomics: Insights into Driver Mutations - March 10, 2015

Seek and destroy: Relating cancer drivers to therapiesExternal Web Site Icon
E. Martinez-Ledesma et al. Cell, March 9, 2015

In silico prescription of anticancer drugs to cohorts of 28 tumor types reveals targeting opportunitiesExternal Web Site Icon
C Rubio-Perez et al. Cancer Cell, March 9, 2015

MADGiC: a model-based approach for identifying driver genes in cancer. Adobe PDF file [PDF 373.56 KB]External Web Site Icon
Keegan D. Korthauer et al. Bioinformatics, January 2015

Identifying driver mutations in sequenced cancer genomes: computational approaches to enable precision medicine.External Web Site Icon
Benjamin J Raphael et al. Genome Medicine 2014

Novel recurrently mutated genes in African American colon cancers.External Web Site Icon
Guda K et al. Proc Natl Acad Sci U S A. 2015 Jan 12

Sparse expression bases in cancer reveal tumor drivers.External Web Site Icon
Logsdon BA, et al. Nucleic Acids Res. 2015 Jan 12

Patient-specific driver gene prediction and risk assessment through integrated network analysis of cancer omics profiles.External Web Site Icon
Bertrand D, et al. Nucleic Acids Res. 2015 Jan 8

Identification of constrained cancer driver genes based on mutation timing.External Web Site Icon
Sakoparnig T, et al. PLoS Comput Biol. 2015 Jan 8;11(1):e1004027

CaMoDi: a new method for cancer module discovery.External Web Site Icon
Manolakos A, et al. BMC Genomics. 2014 Dec 12;15 Suppl 10:S8.

VHL, the story of a tumour suppressor gene.External Web Site Icon
Gossage L, et al. Nat Rev Cancer. 2014 Dec 23;15(1):55-64

Targeting the MET pathway for potential treatment of NSCLC.External Web Site Icon
Li A, et al. Expert Opin Ther Targets. 2014 Dec 23:1-12

Deciphering oncogenic drivers: from single genes to integrated pathways.External Web Site Icon
Chen J, et al. Brief Bioinform. 2014 Nov 5.

Driver and passenger mutations in cancer.External Web Site Icon
Pon JR, et al. Annu Rev Pathol. 2014 Oct 17

Hereditary Cancer Genetic Testing: Where are We? - December 18, 2014

NCI paper:Prevalence and correlates of receiving and sharing high-penetrance cancer genetic test results: Findings from the Health Information National Trends SurveyExternal Web Site Icon
Taber J.M. et al Public Health Genomics, January 2015

Clinical decisions: Screening an asymptomatic person for genetic risk--polling resultsExternal Web Site Icon
Schulte J, et al. N Engl J Med 2014 Nov;371(20):e30

Testing for hereditary breast cancer: Panel or targeted testing? Experience from a clinical cancer genetics practice.External Web Site Icon
Doherty J, J Genet Couns. 2014 Dec 5

Hereditary colorectal cancer syndromes: American Society of Clinical Oncology clinical practice guideline endorsement of the familial risk-colorectal cancer: European Society for Medical Oncology clinical practice guidelines.External Web Site Icon
Stoffel EM, et al. J Clin Oncol. 2014 Dec 1

Population testing for cancer predisposing BRCA1/BRCA2 mutations in the Ashkenazi-Jewish community: A randomized controlled trial.External Web Site Icon
Manchanda R, et al. J Natl Cancer Inst. 2014 Nov 30;107(1)

Cost-effectiveness of population screening for BRCA mutations in Ashkenazi Jewish women compared with family history-based testing.External Web Site Icon
Manchanda R et al. J Natl Cancer Inst. 2014 Nov 30;107(1). pii: dju380. doi: 10.1093/jnci/dju380. Print 2015 Jan.

Check out our Cancer Genetic Testing  Update Page for additional information and links

Cancer Genomic Tests (October 30, 2014)

Cancer Precision Medicine: Where Are We? - September 18, 2014

NIH announces the launch of 3 integrated precision medicine trials; ALCHEMIST is for patients with certain types of early-stage lung cancer,External Web Site Icon August 2014

National Cancer Institute's Precision Medicine Initiatives for the New National Clinical Trials Network.External Web Site Icon Jeffrey Abrams et al. ASCO Annual Meeting 2014

Personalized medicine: Special treatment.External Web Site Icon
Michael Eisenstein. Nature, September 11, 2014

Why the controversy? Start sequencing tumor genes at diagnosis. Tumor sequencing at the time of diagnosis can give significant insight for successful cancer treatment,External Web Site Icon by Shelly Gunn, Genetic Engineering & Biotechnology News, Sep 10

National Cancer Institute information: Precision medicine and targeted therapyExternal Web Site Icon

Genomics and precision oncology: What's a targeted therapy for cancer?External Web Site Icon An updated list of approved drugs from the National Cancer Institute (2014)

Therapy: This time it's personalExternal Web Site Icon
Gravitz L Nature 509, S52-S54 2014 May 29

Multi-marker solid tumor panels using next-generation sequencing to direct molecularly targeted therapiesExternal Web Site Icon
Michael Marrone, et al. PLoS Currents Evidence on Genomic Tests 2014 May 27

Impact of cancer genomics on precision medicine for the treatment of cancer,External Web Site Icon from the National Cancer Institute

Cancer genomics and precision medicine in the 21st century Adobe PDF file [PDF 2.20 MB]External Web Site Icon, power point presentation from the National Human Genome Research Institute